Prognostic Significance of MYC Rearrangement and Translocation Partner in Diffuse Large B-Cell Lymphoma: A Study by the Lunenburg Lymphoma Biomarker Consortium.

MLA

Rosenwald, Andreas, et al. “Prognostic Significance of MYC Rearrangement and Translocation Partner in Diffuse Large B-Cell Lymphoma: A Study by the Lunenburg Lymphoma Biomarker Consortium.” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, vol. 37, no. 35, Dec. 2019, pp. 3359–68. EBSCOhost, https://doi.org/10.1200/JCO.19.00743.

APA

Rosenwald, A., Bens, S., Advani, R., Barrans, S., Copie-Bergman, C., Elsensohn, M.-H., Natkunam, Y., Calaminici, M., Sander, B., Baia, M., Smith, A., Painter, D., Pham, L., Zhao, S., Ziepert, M., Jordanova, E. S., Molina, T. J., Kersten, M. J., Kimby, E., … Maucort-Boulch, D. (2019). Prognostic Significance of MYC Rearrangement and Translocation Partner in Diffuse Large B-Cell Lymphoma: A Study by the Lunenburg Lymphoma Biomarker Consortium. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 37(35), 3359–3368. https://doi.org/10.1200/JCO.19.00743

Chicago

Rosenwald, Andreas, Susanne Bens, Ranjana Advani, Sharon Barrans, Christiane Copie-Bergman, Mad-Helenie Elsensohn, Yaso Natkunam, et al. 2019. “Prognostic Significance of MYC Rearrangement and Translocation Partner in Diffuse Large B-Cell Lymphoma: A Study by the Lunenburg Lymphoma Biomarker Consortium.” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 37 (35): 3359–68. doi:10.1200/JCO.19.00743.